{"result": "(\"entity\"<|>AMERICAN DIABETES ASSOCIATION<|>ORGANIZATION<|>The American Diabetes Association (ADA) is an organization that provides guidelines and recommendations for the treatment of diabetes, including the recommendation for bariatric surgery in patients with Type 2 Diabetes Mellitus (DM2).)\n##\n(\"entity\"<|>BARIATRIC SURGERY<|>EVENT<|>Bariatric surgery is a medical procedure recommended for patients with obesity and Type 2 Diabetes Mellitus, aimed at achieving weight loss and improving metabolic control.)\n##\n(\"entity\"<|>DIABETES MELLITUS TYPE 2<|>EVENT<|>Type 2 Diabetes Mellitus (DM2) is a chronic condition that affects the way the body processes blood sugar (glucose) and is often associated with obesity.)\n##\n(\"entity\"<|>CUMMINGS DE<|>PERSON<|>Cummings DE is a researcher who has contributed to the understanding of metabolic surgery for the treatment of Type 2 Diabetes in obese individuals.)\n##\n(\"entity\"<|>RUBINO F<|>PERSON<|>Rubino F is a researcher known for his work on metabolic surgery and its effects on Type 2 Diabetes management.)\n##\n(\"entity\"<|>RUBIO MA<|>PERSON<|>Rubio MA is a researcher involved in the positioning documents regarding metabolic surgery for patients with Type 2 Diabetes Mellitus.)\n##\n(\"relationship\"<|>AMERICAN DIABETES ASSOCIATION<|>BARIATRIC SURGERY<|>The American Diabetes Association recommends bariatric surgery for patients with Type 2 Diabetes Mellitus and obesity based on their guidelines.<|>8)\n##\n(\"relationship\"<|>BARIATRIC SURGERY<|>DIABETES MELLITUS TYPE 2<|>Bariatric surgery is a treatment option for patients suffering from Type 2 Diabetes Mellitus, particularly those with obesity.<|>7)\n##\n(\"relationship\"<|>CUMMINGS DE<|>RUBINO F<|>Cummings DE and Rubino F are both researchers who have published work on metabolic surgery for the treatment of Type 2 Diabetes in obese individuals.<|>6)\n##\n(\"relationship\"<|>RUBIO MA<|>AMERICAN DIABETES ASSOCIATION<|>Rubio MA contributed to the positioning documents of the American Diabetes Association regarding metabolic surgery for Type 2 Diabetes Mellitus.<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 30 kg/m², cuando exista mal control metabólico tras tratamiento médico intensivo.\n\nCOMENTARIO\n\nDesde 2017, la American Diabetes Association (ADA) considera que la cirugía bariátrica debe recomendarse en todos los pacientes con DM2 con IMC ≥ 40 kg/m² o en aquellos con IMC ≥ 35 kg/m² con hiperglucemia no controlada con medicación (grado de recomendación A).\n---\n# OBESIDAD, LÍPIDOS Y TRASTORNOS ELECTROLÍTICOS\n\nLa cirugía metabólica debe considerarse como una opción en todos los pacientes con un IMC de 30-35 kg/m² (tabla 3), con hiperglucemia mantenida cuando exista hiperglucemia pese a tratamiento médico (incluyendo insulina) (grado de recomendación B).\n\n## Tabla 3. Tipo de tratamiento en función de categorías de IMC\n\n| CATEGORÍAS DE IMC |       |       |       |       |     |\n|--------------------|-------|-------|-------|-------|-----|\n| Tratamiento        | 25-26,9 | 27-29,9 | 30-34,9 | 35-39,9 | ≥40 |\n| Dieta              | √     | √     | √     | √     | √   |\n| Fármacos           |       | √     | √     | √     | √   |\n| Cirugía            |       |       | √     | √     | √   |\n\nLa cirugía metabólica debe realizarse en centros experimentados con un alto volumen de cirugías y con equipos multidisciplinares en el manejo de la diabetes y la cirugía.\n\nLas evidencias científicas de que la cirugía metabólica facilitaba la remisión de la DM2 tienen más de 10 años de constancia, pero la ADA no se ha hecho eco hasta recientemente, una vez se ha tenido constancia reiterada de mejoría o remisión de la DM2 con cirugía en ensayos clínicos aleatorizados (dieta vs. cirugía).\n\nReferencias:\n- American Diabetes Association. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes 2018. Diabetes Care. 2018;41(Suppl 1):S65-S72.\n- Cummings DE, Rubino F. Metabolic surgery for the treatment of type 2 diabetes in obese individuals. Diabetologia. 2018;61(2):257-64.\n- Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Diabetes Care. 2016;39(6):861-77.\n- Rubio MA, Monereo S, Lecube A, Resa J, Masdevall C, de la Cruz Vigo F, et al. Documento de posicionamiento de las Sociedades SEEN-SECO-SEEDO-SED sobre cirugía metabólica para pacientes con diabetes mellitus tipo 2. Endocrinol Nutr. 2013;60(10):547-8.\n\nSi la HbA1c está por debajo del 6,5% y la glucemia es inferior a 126 mg/dl (en ausencia de medicación), se considera remisión parcial.\n\nEs importante conocer la definición empleada, porque con la más estricta aproximadamente un 50% de los diabéticos intervenidos se encuentran en remisión completa, pero la cifra asciende a un 70-80% (según técnicas) si el criterio es la remisión parcial (técnicamente estaríamos en una \"prediabetes\").\n\nLos factores que contribuyen a una remisión de la diabetes se relacionan con la reserva pancreática (péptido C), tratamiento con insulina, tiempo de evolución de la DM2, edad y haber conseguido una mayor o menor pérdida de peso tras la cirugía.\n\nNo obstante, y a efectos clínicos prácticos, no debemos considerar un fracaso aquellos pacientes que no alcancen los criterios de remisión completa o parcial, si su concentración de HbA1c se encuentra, por ejemplo, por debajo del 6% tomando 1 comp./día de metformina, cuando quizás antes de la cirugía estaba con más de 100 UI de insulina y una HbA1c del 9%.\n\nNOTA: mejor emplear el término \"remisión\", porque la diabetes, como todas las enfermedades crónicas, se controla, pero no se \"cura\" (se curan los procesos agudos, como una gripe, una apendicitis...).\n\nReferencias:\n- Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133-5.\n- Ramos-Levi AM, Matia P, Cabrerizo L, Barabash A, Sanchez-Pernaute A, Calle-Pascual AL, et al. Statistical models to predict type 2 diabetes remission after bariatric surgery.\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}